Prevacus is a development stage company focusing on a new treatment for concussions. Prevacus is commercializing and developing a proprietary formalization, Prevasol, which can successfully treat and prevent the effects of a mild traumatic brain injury (mTBI-concussion).

Prevacus Inc. is a spun out from Florida State University. Dr. VanLandingham, founder of Prevacus, serves as a professor of neuroscience at Florida State University Department of Biomedical Sciences.